Related Experiment Video

Updated: Oct 23, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.5K

Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail

A T L Fiolet1,2,3,4, T S J Opstal5,6, M J M Silvis1

  • 1Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|August 17, 2021
PubMed

Insights

Low-dose colchicine significantly reduces cardiovascular events in patients with coronary disease by targeting inflammation. This anti-inflammatory approach offers a new therapeutic option for managing atherosclerosis and improving patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Biology
  • Pharmacology

Background:

  • Patients with coronary disease face persistent high risk for cardiovascular events despite optimal treatments.
  • Inflammatory pathways significantly drive atherosclerosis progression in these individuals.
  • Recent advancements translate inflammatory biology into clinical therapeutic strategies.

Purpose of the Study:

  • To evaluate the clinical efficacy of low-dose colchicine in reducing cardiovascular events in patients with coronary syndromes.
  • To explore the anti-inflammatory mechanisms of colchicine in the context of atherosclerosis.

Main Methods:

  • Clinical trials assessing composite and individual major cardiovascular outcomes in patients with acute and chronic coronary syndromes.
  • Investigation of colchicine's effects on inflammatory markers, including neutrophil recruitment, inflammasome activity, and platelet morphology/aggregation.

Main Results:

  • Low-dose colchicine demonstrated a clinically relevant reduction in major cardiovascular outcomes.
  • Colchicine's anti-inflammatory effects involve modulating neutrophil adhesion, inhibiting the inflammasome, and altering platelet characteristics.

Conclusions:

  • Colchicine represents a valuable therapeutic option for reducing cardiovascular risk in patients with coronary syndromes.
  • Further research will refine colchicine's role and identify optimal patient candidates for anti-inflammatory therapies in atherosclerosis.
Keywords:
Acute coronary syndromeAtherosclerosisChronic coronary diseaseInflammation

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

25.8K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.2K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
75
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
413
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
72
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
57
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
68
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
523